IBIO Stock Alert: Analyst Call Sends Shares of Pharma iBio Soaring

Shares of IBIO stock are taking off on Friday after an analyst from Cantor Fitzgerald initiated an Overweight rating and $3 price target. More 

7 Dividend Aristocrats That Will Outlive Us All

These seven Dividend Aristocrats are among the royalty of passive-income generator companies More 

XL Fleet News: New Analyst Call Revs Up XL Stock

XL Fleet (XL) stock is on the rise Friday following a new rating and price target for the stock from BTIG analyst Gregory Lewis. More 

ADMP Stock: 4 Things to Know About Adamis Pharma Today as Shares Rocket Again

Adamis Pharma (ADMP) stock is taking off on Friday after a week of positive news for the company, including a deal with Walgreens. More 

3 Entertainment Stocks That Will Thrive in 2021

With the post-pandemic recovery underway, these three entertainment stocks appear poised to outperform the stock market in 2021. More 

EVgo SPAC Merger News: CLII Stock Soars as It Plans to Take the EV Fast-Charging Play Public

Climate Change Crisis Real Impact (CLII) stock is on the rise after announcing plans to take EVgo public via a SPAC merger. More 

A Play on the Biggest Scientific Breakthrough of the Century

There are only a handful of large, well-established gene editors with robust and mature therapy pipelines in the world today. Of those, one that stands out is a $4.8 billion biotechnology company by the name of Editas Medicine (NASDAQ:EDIT). More